Kymriah Will Only Have Limited Impact on Health Finances: Minister

Health Minister Takumi Nemoto Health Minister Takumi Nemoto said on February 26 that Novartis Pharma’s CAR-T cell therapy Kymriah (tisagenlecleucel) will have “a limited impact on health finances,” with the product expected to target only “250 or so patients.” Kymriah...read more